Cerulean Pharma (DARE) Upgraded to “Sell” by ValuEngine
ValuEngine upgraded shares of Cerulean Pharma (NASDAQ:DARE) from a strong sell rating to a sell rating in a report published on Saturday morning.
Cerulean Pharma (DARE) opened at $2.54 on Friday. Cerulean Pharma has a 12 month low of $2.24 and a 12 month high of $35.80.
WARNING: “Cerulean Pharma (DARE) Upgraded to “Sell” by ValuEngine” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/13/cerulean-pharma-dare-upgraded-to-sell-by-valuengine.html.
Cerulean Pharma Company Profile
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Stock Ratings for Cerulean Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerulean Pharma and related stocks with our FREE daily email newsletter.